Treating Bipolar Depression With Atypical Antipsychotics: Pros, Cons, and Tips

Slideshow

Depression predominates across the lifespan in patients with bipolar disorder. Here: A discussion about (and beyond) the four FDA-approved drugs to treat symptoms.

Related Videos
Related Content
late life TRD

Late-Life Treatment-Resistant Depression

November 20th 2023
Article
Blue Light Blockers: A Behavior Therapy for Mania

Blue Light Blockers: A Behavior Therapy for Mania

October 7th 2021
Podcast
depression

Tackling Treatment-Resistant Depression

November 8th 2023
Article
Blue Light, Depression, and Bipolar Disorder

Blue Light, Depression, and Bipolar Disorder

August 4th 2021
Podcast
brain

The First and Only 5HT1a Receptor Agonist for Major Depressive Disorder

November 1st 2023
Article
Researchers performed a head-to-head trial of vortioxetine versus desvenalfaxine in patients with depression and partial response to SSRIs.

Head-to-Head Comparison of Vortioxetine Versus Desvenalfaxine in Patients With Depression and Partial Response to SSRIs

October 31st 2023
Article
© 2023 MJH Life Sciences

All rights reserved.